Tumor Metabolism and Therapy
A topical collection in Cells (ISSN 2073-4409).
Viewed by 3596
Share This Topical Collection
Editors
Dr. Guohui Sun
Dr. Guohui Sun
E-Mail
Website
Collection Editor
Key Laboratory of Environmental and Viral Oncology, Faculty of Environment and Life, Beijing University of Technology, Beijing 100124, China
Interests: tumor resistance; pharmacology; molecular toxicology; environmental pollutants; computational toxicology
Special Issues, Collections and Topics in MDPI journals
Prof. Dr. Jianhua Wang
Prof. Dr. Jianhua Wang
E-Mail
Website
Collection Editor
Children's Hospital, Capital Institute of Pediatrics, Beijing 100020, China
Interests: developmental biology; birth defect; neural tube defects; translational medicine
Topical Collection Information
Dear Colleagues,
As we know, tumor cells have unique metabolism characteristics from normal cells, namely, they highly rely on aerobic glycolysis to supply energy and a carbon source for survival and growth. This phenomenon is called the Warburg effect, which is associated with radio-resistance and chemo-resistance by generating a chemical reduction milieu (radio-resistance) and extracellular acid microenvironment (immunosuppression), activating DNA damage repair, triggering exosome release (expressing resistance protein), etc. In this case, the metabolism-based therapy will become precise and promising, such as glycolytic inhibitors and other energy inhibitors. However, many elaborate mechanisms related to tumor metabolism changes have yet to be solved. Therefore, this Topical Collection focuses on the following items: (1) tumor metabolism mechanisms, (2) tumor resistance, (3) and metabolism-based therapy. We welcome the submission of research and review papers from all over the world.
Dr. Guohui Sun
Prof. Dr. Jianhua Wang
Collection Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript.
The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs).
Submitted papers should be well formatted and use good English. Authors may use MDPI's
English editing service prior to publication or during author revisions.
Keywords
- tumor metabolsim
- Warburg effect
- resistance
- inhibitors
Published Papers (1 paper)
2023
Open AccessArticle
New Insights into the Impact of Human Papillomavirus on Oral Cancer in Young Patients: Proteomic Approach Reveals a Novel Role for S100A8
by
Marisol Miranda-Galvis, Carolina Carneiro Soares, Carolina Moretto Carnielli, Jaqueline Ramalho Buttura, Raisa Sales de Sá, Estela Kaminagakura, Fabio Albuquerque Marchi, Adriana Franco Paes Leme, Clóvis A. Lópes Pinto, Alan Roger Santos-Silva, Rogerio Moraes Castilho, Luiz Paulo Kowalski and Cristiane Helena Squarize
Cited by 1 | Viewed by 1883
Abstract
Human papillomavirus (HPV) infection has recently been linked to a subset of cancers affecting the oral cavity. However, the molecular mechanisms underlying HPV-driven oral squamous cell carcinoma (OSCC) onset and progression are poorly understood. Methods: We performed MS-based proteomics profiling based on HPV
[...] Read more.
Human papillomavirus (HPV) infection has recently been linked to a subset of cancers affecting the oral cavity. However, the molecular mechanisms underlying HPV-driven oral squamous cell carcinoma (OSCC) onset and progression are poorly understood. Methods: We performed MS-based proteomics profiling based on HPV status in OSCC in young patients, following biological characterization and cell assays to explore the proteome functional landscape. Results: Thirty-nine proteins are differentially abundant between HPV (+) and HPV (−) OSCC. Among them, COPS3, DYHC1, and S100A8 are unfavorable for tumor recurrence and survival, in contrast to A2M and Serpine1, low levels of which show an association with better DFS. Remarkably, S100A8 is considered an independent prognostic factor for lower survival rates, and at high levels, it alters tumor-associated immune profiling, showing a lower proportion of M1 macrophages and dendritic cells. HPV (+) OSCC also displayed the pathogen-associated patterns receptor that, when activated, triggered the S100A8 and NFκB inflammatory responses. Conclusion: HPV (+) OSCC has a peculiar microenvironment pattern distinctive from HPV (−), involving the expression of pathogen-associated pattern receptors, S100A8 overexpression, and NFκB activation and responses, which has important consequences in prognosis and may guide therapeutic decisions.
Full article
►▼
Show Figures
